Health · Medical Research · 3 hrs ago
CBD Did Not Beat Placebo for Severe Behavioral Problems in Children
Cannabidiol, or CBD, was no better than a placebo for severe behavioral problems in children with intellectual disabilities.
The study involved children with intellectual disabilities who had severe behavioral problems.
Researchers ran a randomized clinical trial in Australia, assigning participants to treatment groups.
A placebo is an inactive treatment used to compare results with the medicine being tested.
The trial found CBD did not outperform the placebo for these behavioral problems.
The result concerns this use of CBD in this group of children; no next steps are stated.
Cannabidiol was no better than placebo for severe behavioral problems in children with intellectual disabilities.
The finding came from a randomized clinical trial in Australia.
The report describes an intention-to-treat analysis of patients who were randomized.
The article was published by MedPage Today on November 16, 2026.
- Who
- Children with intellectual disabilities and severe behavioral problems.
- What
- A randomized clinical trial found CBD was no better than placebo.
- When
- November 16, 2026, the article’s publication date.
- Where
- Australia.
- Why
- Not stated.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Intervention
- Cannabidiol (CBD)
- Comparator
- Placebo
- Population
- Children with intellectual disabilities and severe behavioral problems
- Study
- Randomized clinical trial
- Location
- Australia
- Publication date
- November 16, 2026